Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 21.43%56.18B | -5.20%46.26B | -1.75%13.4B | -3.13%10.72B | -10.18%10.55B | -6.12%11.58B | 16.28%48.8B | 5.41%13.64B | 17.11%11.07B | 29.27%11.75B |
| Cost of revenue | 17.19%36.17B | -3.24%30.86B | 2.91%8.71B | 2.89%7.41B | -8.89%7.26B | -9.42%7.48B | 16.79%31.89B | 1.32%8.47B | 12.72%7.2B | 32.48%7.97B |
| Gross profit | 29.92%20.01B | -8.90%15.4B | -9.37%4.69B | -14.36%3.31B | -12.88%3.29B | 0.55%4.11B | 15.34%16.91B | 12.85%5.17B | 26.27%3.86B | 22.99%3.78B |
| Operating expense | 4.29%15.14B | 7.39%14.52B | 1.36%3.88B | 13.54%3.65B | 7.47%3.51B | 8.33%3.49B | 20.00%13.52B | 20.99%3.83B | 14.82%3.21B | 21.29%3.26B |
| Operating profit | 451.59%4.87B | -73.93%882.57M | -39.82%811.68M | -151.23%-335.29M | -141.73%-215.18M | -28.34%621.36M | -0.15%3.39B | -5.22%1.35B | 147.22%654.54M | 35.01%515.6M |
| Net non-operating interest income (expenses) | 12.73%313.49M | 76.81%278.1M | -4.00%84.55M | 141.00%85.74M | 218.86%76.78M | 224.77%31.04M | 415.12%157.29M | 588.10%88.08M | 525.96%35.58M | 314.37%24.08M |
| Non-operating interest income | 17.75%424.56M | 44.03%360.57M | 0.23%100.1M | 94.41%105.71M | 123.66%106.15M | -0.08%48.61M | 733.16%250.35M | 564.81%99.87M | 1,092.48%54.38M | 699.93%47.46M |
| Non-operating interest expense | 51.58%111.06M | 4.88%73.27M | 125.32%15.55M | 6.23%19.97M | -13.69%20.18M | -15.45%17.57M | 1.82%69.86M | -68.23%6.9M | 1.16%18.8M | 63.19%23.38M |
| Total other finance cost | ---- | -60.37%9.19M | --0 | --0 | ---- | ---- | 104.42%23.2M | --4.89M | --0 | --0 |
| Net investment income | -209.28%-542.28M | 154.98%496.24M | 29.78%330.83M | 1,986.66%274.77M | 19.08%-209.77M | -45.95%100.41M | -65.53%194.62M | -18.56%254.92M | -92.08%13.17M | -489.92%-259.23M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -265.73%-190.83M | 20.61%-52.18M | -113.36%-2.18M | -50M | 27.38%-65.72M | 16.31M | ||||
| Income from associates and other participating interests | 63.69%94.01M | 279.47%57.43M | 12.69%18.72M | 185.19%20.17M | -62.79%4.17M | 30.73%14.38M | -50.41%15.14M | 1,582.16%16.62M | -1,372.69%-23.67M | -0.76%11.19M |
| Special income (charges) | 169.13%237.25M | 108.86%88.15M | 113.06%88.15M | -566.34%-995.28M | -675.21M | |||||
| Less:Restructuring and mergern&acquisition | --0 | ---112.98M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Less:Other special charges | -715.55%-166M | --26.97M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | -3,231.18%-71.25M | -100.21%-2.14M | -100.32%-2.14M | ---- | ---- | ---- | 566.34%995.28M | --675.21M | ---- | ---- |
| Other non-operating income (expenses) | -77.83%40.28M | -75.79%181.71M | -102.90%-3.06M | -71.08%145.73M | 29.28%35.59M | -96.97%3.44M | -36.23%750.57M | -43.65%105.54M | 148.20%503.94M | -94.06%27.53M |
| Income before tax | 149.49%4.82B | -43.88%1.93B | 15.03%1.33B | -81.94%141.12M | -196.63%-308.42M | -35.07%770.63M | -29.36%3.44B | -36.32%1.16B | 63.44%781.44M | -65.00%319.18M |
| Income tax | 18.54%1.23B | -22.82%1.04B | 52.19%483.56M | -58.75%133.25M | -102.67%-4.16M | -22.39%426.32M | -3.97%1.35B | -5.65%317.73M | 13.31%323.06M | -30.76%156.05M |
| Net income | 301.83%3.59B | -57.40%893.07M | 0.93%845.14M | -98.28%7.87M | -286.51%-304.25M | -46.00%344.31M | -39.61%2.1B | -43.31%837.32M | 137.51%458.38M | -76.24%163.13M |
| Net income continuous operations | 301.83%3.59B | -57.40%893.07M | 0.93%845.14M | -98.28%7.87M | -286.51%-304.25M | -46.00%344.31M | -39.61%2.1B | -43.31%837.32M | 137.51%458.38M | -76.24%163.13M |
| Noncontrolling interests | 93.14%170.4M | 92.87%88.22M | -50.35%14.81M | 4.61%47.03M | 21.72%-17.98M | 831.85%44.37M | 224.16%45.74M | 1,170.02%29.82M | 1,747.45%44.96M | -54.07%-22.97M |
| Net income attributable to the company | 324.70%3.42B | -60.75%804.85M | 2.83%830.33M | -109.47%-39.16M | -253.83%-286.27M | -53.40%299.94M | -41.55%2.05B | -45.24%807.5M | 111.22%413.42M | -73.47%186.1M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 324.70%3.42B | -60.75%804.85M | 2.83%830.33M | -109.47%-39.16M | -253.83%-286.27M | -53.40%299.94M | -41.55%2.05B | -45.24%807.5M | 111.22%413.42M | -73.47%186.1M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 336.73%24.85 | -60.93%5.69 | 2.35%5.87 | -109.37%-0.275 | -252.27%-2.01 | -53.99%2.105 | -46.85%14.565 | -50.04%5.735 | 95.67%2.935 | -76.46%1.32 |
| Diluted earnings per share | 336.19%24.645 | -60.28%5.65 | 4.36%5.87 | -109.63%-0.2797 | -252.27%-2.01 | -51.85%2.085 | -43.13%14.225 | -45.76%5.625 | 124.76%2.905 | -74.54%1.32 |
| Dividend per share | 0.00%2.25 | 0.00%2.25 | 0.00%2.25 | 0 | 0 | 0 | 0.00%2.25 | 0.00%2.25 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |